JENNIFER CORRALES: Open Payments
NPI 1780109553 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,780 in 85 payments from 23 companies in 2025. Trend: 2023 $2,059 · 2024 $2,414 · 2025 $2,780
Food & beverage: $2,739Education: $40
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $364 |
| Merck Sharp & Dohme LLC | 9 | $222 |
| PFIZER INC. | 12 | $221 |
| Novartis Pharmaceuticals Corporation | 8 | $202 |
| E.R. Squibb & Sons, L.L.C. | 4 | $194 |
| Kestra Medical Technology Services, Inc. | 2 | $180 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $170 |
| Novo Nordisk Inc | 4 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $161 |
| HEARTFLOW, INC. | 2 | $152 |
Products named: VERQUVO, LEQVIO, Assure WCD, ELIQUIS, CAMZYOS, JARDIANCE, SYMPLICITY G3, Kerendia.
Industry payments across TX — which companies pay providers there.
